Abstract
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Lingling Qiu, Ting Zeng, Chengyin Wang
Abstract
Authors
Institutions
Provenance
crossref
Confidence 100%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Clinical and paraclinical characterizations, management, and prognosis in DPPX antibody-associated encephalitis: A systematic review
10.1212/nxi.0000000000200350 · 2025
Case report: Treatment of delayed tremor episodes in a patient with DPPX antibody encephalitis
10.3389/fimmu.2025.1594823 · 2025
Autoimmune encephalitis
10.1038/s41572-025-00650-1 · 2025
Encephalitis and antibodies to dipeptidyl-peptidase-like protein-6, a subunit of Kv4.2 potassium channels
10.1002/ana.23756 · 2013
Chinese expert consensus on diagnosis and treatment of autoimmune encephalitis
10.3760/cma.j.cn113694-20220219-00118 · 2022
Clinical features and prognosis in Chinese patients with dipeptidyl-peptidase-like protein 6 antibody-associated encephalitis
10.3389/fneur.2021.817896 · 2022
Case report: Successful treatment of an anti-D2R and DPPX antibody-associated autoimmune encephalitis patient with high-dose methylprednisolone and intravenous immunoglobulin
10.3389/fimmu.2024.1338714 · 2024
Immunological bases of paraneoplastic cerebellar degeneration and therapeutic implications
10.3389/fimmu.2020.00991 · 2020
Case report: Paraneoplastic cerebellar degeneration associated with anti-Yo antibody successfully treated with ofatumumab
ror
Confidence 99%
openalex
Confidence 95%
doaj
Confidence 92%
datacite
Confidence 0%
10.3389/fimmu.2024.1476397 · 2024
Cerebellar degeneration-related proteins 2 and 2-like are present in ovarian cancer in patients with and without Yo antibodies
10.1007/s00262-017-2041-8 · 2017
Clinical and tumor features of patients with immune checkpoint inhibitor-related neurological disorders and anti-Yo antibodies
10.1177/17562864251377559 · 2025
Mimickers of autoimmune encephalitis: A literature review
10.1177/03000605241248050 · 2024
Molecular mimicry as a mechanism of autoimmune disease
10.1007/s12016-011-8294-7 · 2012
Two cases of anti-dipeptidyl peptidase-like protein 6 antibody-associated encephalitis
10.3969/j.issn.1006-2963.2024.02.013 · 2024
Heart Failure Association of the European Society of Cardiology practical guidance on the use of natriuretic peptide concentrations
10.1002/ejhf.1494 · 2019
Autoimmunenzephalitis – ein update [Autoimmune encephalitis-an update
10.1007/s00115-022-01411-1 · 2023
Oro-bucco-lingual dyskinesia, weight loss, and cognitive decline in anti-DPPX antibody-mediated encephalitis
10.1002/mdc3.13058 · 2020
Co-occurrence of antibodies against dipeptidyl-peptidase-like protein-6 and aquaporin-4 during a case of paraneoplastic encephalitis
10.1016/j.clineuro.2020.106093 · 2020
Disease characteristics, treatment, and prognosis of Chinese patients with autoimmune encephalitis: A retrospective study
10.12182/20220160206 · 2022
Diagnosis and treatment of autoimmune cerebellar ataxia
10.3760/cma.j.cn113694-20240305-00133 · 2024
Paraneoplastic cerebellar degeneration associated with anti-Yo antibodies in uterine papillary serous carcinoma
10.1136/ijgc-2021-003077 · 2022
Paraneoplastic cerebellar degeneration associated with anti-Yo antibodies in uterine papillary serous carcinoma
10.1136/ijgc-2021-003077 · doi-reference
Diagnosis and treatment of autoimmune cerebellar ataxia
10.3760/cma.j.cn113694-20240305-00133 · doi-reference
Disease characteristics, treatment, and prognosis of Chinese patients with autoimmune encephalitis: A retrospective study
10.12182/20220160206 · doi-reference
Co-occurrence of antibodies against dipeptidyl-peptidase-like protein-6 and aquaporin-4 during a case of paraneoplastic encephalitis
10.1016/j.clineuro.2020.106093 · doi-reference
Oro-bucco-lingual dyskinesia, weight loss, and cognitive decline in anti-DPPX antibody-mediated encephalitis
10.1002/mdc3.13058 · doi-reference
Autoimmunenzephalitis – ein update [Autoimmune encephalitis-an update
10.1007/s00115-022-01411-1 · doi-reference
Heart Failure Association of the European Society of Cardiology practical guidance on the use of natriuretic peptide concentrations
10.1002/ejhf.1494 · doi-reference
Two cases of anti-dipeptidyl peptidase-like protein 6 antibody-associated encephalitis
10.3969/j.issn.1006-2963.2024.02.013 · doi-reference
Molecular mimicry as a mechanism of autoimmune disease
10.1007/s12016-011-8294-7 · doi-reference
Mimickers of autoimmune encephalitis: A literature review
10.1177/03000605241248050 · doi-reference
Clinical and tumor features of patients with immune checkpoint inhibitor-related neurological disorders and anti-Yo antibodies
10.1177/17562864251377559 · doi-reference
Cerebellar degeneration-related proteins 2 and 2-like are present in ovarian cancer in patients with and without Yo antibodies
10.1007/s00262-017-2041-8 · doi-reference
Case report: Paraneoplastic cerebellar degeneration associated with anti-Yo antibody successfully treated with ofatumumab
10.3389/fimmu.2024.1476397 · doi-reference
Immunological bases of paraneoplastic cerebellar degeneration and therapeutic implications
10.3389/fimmu.2020.00991 · doi-reference
Case report: Successful treatment of an anti-D2R and DPPX antibody-associated autoimmune encephalitis patient with high-dose methylprednisolone and intravenous immunoglobulin
10.3389/fimmu.2024.1338714 · doi-reference
Clinical features and prognosis in Chinese patients with dipeptidyl-peptidase-like protein 6 antibody-associated encephalitis
10.3389/fneur.2021.817896 · doi-reference
Chinese expert consensus on diagnosis and treatment of autoimmune encephalitis
10.3760/cma.j.cn113694-20220219-00118 · doi-reference
Encephalitis and antibodies to dipeptidyl-peptidase-like protein-6, a subunit of Kv4.2 potassium channels
10.1002/ana.23756 · doi-reference
Autoimmune encephalitis
10.1038/s41572-025-00650-1 · doi-reference
Case report: Treatment of delayed tremor episodes in a patient with DPPX antibody encephalitis
10.3389/fimmu.2025.1594823 · doi-reference
Clinical and paraclinical characterizations, management, and prognosis in DPPX antibody-associated encephalitis: A systematic review
10.1212/nxi.0000000000200350 · doi-reference